Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting
about
Are T cells the only HIV-1 reservoir?HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based SchemesDeclines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, CanadaThe UNAIDS 90-90-90 target: a clear choice for ending AIDS and for sustainable health and developmentEvaluation of novel Saquinavir analogs for resistance mutation compatibility and potential as an HIV-Protease inhibitor drug.Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort.Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination SurveyA Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission networkIncreasing HIV testing among hard-to-reach groups: examination of RAPID, a community-based testing service in Queensland, AustraliaA universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.The North American opioid epidemic: current challenges and a call for treatment as preventionMaximizing the benefits of antiretroviral therapy for key affected populationsPredictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.Process monitoring of an HIV treatment as prevention program in British Columbia, Canada.Treatment as prevention--where next?Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective studyIncarceration of people living with HIV/AIDS: implications for treatment-as-prevention.Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013.Symptoms of Autonomic Dysfunction in Human Immunodeficiency Virus.Gay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada.Optimizing an HIV testing program using a system dynamics model of the continuum of careA Pilot Trial of a Sexual Health Counseling Intervention for HIV-Positive Gay and Bisexual Men Who Report Anal Sex without Condoms.Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysisCharacterizing retention in HAART as a recurrent event process: insights into 'cascade churn'.The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada.HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study.Non-HIV-related health care utilization, demographic, clinical and laboratory factors associated with time to initial retention in HIV care among HIV-positive individuals linked to HIV care.Structural Barriers to Antiretroviral Therapy Among Sex Workers Living with HIV: Findings of a Longitudinal Study in Vancouver, CanadaUse of Compassionate Supply of Antiretroviral Drugs to Avoid Treatment Interruptions or Delayed Treatment Initiation among HIV-Positive Patients Living in Ontario: A Retrospective Review.Substance use, sexual behaviour and prevention strategies of Vancouver gay and bisexual men who recently attended group sex events.Sex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada.Superior Effects of Antiretroviral Treatment among Men Who have Sex with Men Compared to Other HIV At-Risk Populations in a Large Cohort Study in Hunan, ChinaImprovements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian settingIdentification of Vimentin as a Potential Therapeutic Target against HIV Infection
P2860
Q28078850-133B3BCF-3A50-4DD2-A1D9-98C8432BBAA9Q28551618-87775A7E-18D6-44D9-A159-67F63AAAE608Q28610686-B1F0BD87-8728-4E1D-BD5B-19571613ED1EQ30382647-450FC250-D241-47C7-A370-145ED76FDD6FQ30391405-AED10B30-283A-49C1-91A8-2F1D11FF4737Q30840171-D69A938F-170B-4E67-BCB6-AD29C1CD8AB4Q30948574-6C62F5EB-81B7-4295-B79D-A7CA23269DFDQ30979829-C119D1BA-E443-4391-B17C-77B350E23B17Q31162537-D31D4507-4594-47E7-B99A-46E073D31668Q33589187-BA3F95AB-1CF1-4B76-BE5D-F2E8A0217FABQ33617718-D4769347-AB6F-4721-B8AA-B5DD33B20A7CQ33626374-EAC65EB6-D2E1-4C80-AC13-392DACEFAB6FQ33667492-D38B413B-371F-4468-81D0-F9C8C3B380ABQ33923436-EBE19ABC-B55F-4D33-8DE6-F9E045C72938Q34491134-1ABD9784-65BF-4D35-924E-A5AF806B93EAQ34640731-64477B9E-B9C0-4498-AEB9-9F3FCC3D5487Q34718341-12BF8102-BACF-4F42-9723-53A7DA77AF2EQ34993280-0B01CD83-CBFC-4DAD-9851-108A80A03ADEQ35171945-DD3F1D1A-0CFF-49BF-83CF-EDC4E39E146AQ35194961-055E402A-510F-4022-A03C-AA67F4CA9133Q35684087-C69D3AB9-E0D6-4396-A31E-92BE364318A3Q35935648-C6D10ACF-C79A-4C94-A336-816F10982FE1Q35947588-EB4C9D76-CF39-4F8B-8F49-C7925F5872DDQ35977415-29816073-2B55-4AC3-B097-6255EFC1894EQ35982207-A27EAC31-9927-4C46-BE7C-D9D159B7DFF8Q36045908-20E54276-98EE-4E05-9516-BD5DE0BE2F29Q36063587-8D70E069-20D3-4A43-844D-F958589E9ECEQ36137725-C7B0E118-1B2C-4C28-A513-3BBC58EC35FCQ36158371-8B66C7C3-2D8F-432E-AA8A-E4767B2BF3F6Q36175183-A84048BE-3704-4D83-A9B3-9A541FC1E29FQ36284574-FEBB9389-1D76-4C59-ABC0-9C5675E96B8FQ36322539-20E15CBA-CE35-4BF8-B074-E5B09B9B3CECQ36404797-69F76EE4-3112-4FF9-9D4A-5274D7272A28Q36441211-A0BE67A5-9CD6-4280-92CF-D33ED8F6F2E5Q36565336-24549FAE-5BF3-4E24-9455-873928053220Q36636528-2E3B056F-1F2F-4D25-AAAF-B2F9E8298278Q36663552-B09771F7-DD45-4F43-BB02-29DC77A82486Q36732366-67A2FBA7-8451-44B9-9BE2-59A06656B8EEQ36814748-7A6597AE-1B13-4FCA-82E3-3D825A30FDD8Q37049947-4B500B4E-9F51-4074-804B-C100F043C7D9
P2860
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expansion of HAART coverage is ...... perience in a Canadian setting
@ast
Expansion of HAART coverage is ...... perience in a Canadian setting
@en
Expansion of HAART coverage is ...... perience in a Canadian setting
@nl
type
label
Expansion of HAART coverage is ...... perience in a Canadian setting
@ast
Expansion of HAART coverage is ...... perience in a Canadian setting
@en
Expansion of HAART coverage is ...... perience in a Canadian setting
@nl
prefLabel
Expansion of HAART coverage is ...... perience in a Canadian setting
@ast
Expansion of HAART coverage is ...... perience in a Canadian setting
@en
Expansion of HAART coverage is ...... perience in a Canadian setting
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Expansion of HAART coverage is ...... perience in a Canadian setting
@en
P2093
Benita Yip
Bohdan Nosyk
David Moore
Kate Shannon
Lillian Lourenço
Mark Gilbert
P Richard Harrigan
Perry Kendall
Reka Gustafson
Rolando Barrios
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0087872
P407
P577
2014-01-01T00:00:00Z